These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography]. Bello Mimbrera G, García de León M, de la Torre Gutiérrez S, Montero Vázquez J, Torres Salcines J, de la Torre Fernández JM. Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914 [Abstract] [Full Text] [Related]
16. [Treatment of hepatic encephalopathy with flumazenil]. Elkjaer JM, Jensen TU, Emborg J. Ugeskr Laeger; 2000 Aug 28; 162(35):4681-4. PubMed ID: 10986901 [Abstract] [Full Text] [Related]
17. [The quantitative electroencephalogram in a case of acute hepatic encephalopathy treated with flumazenil]. Frenkel AL, Hermant JL, Blaise M, Volter F, Pourriat JL. Cah Anesthesiol; 1991 Aug 28; 39(1):61-2. PubMed ID: 2054699 [No Abstract] [Full Text] [Related]
18. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M. Gastroenterology; 1989 Sep 28; 97(3):744-50. PubMed ID: 2546850 [Abstract] [Full Text] [Related]
19. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G. Hepatology; 1998 Aug 28; 28(2):374-8. PubMed ID: 9695999 [Abstract] [Full Text] [Related]